Figure 1.
Decrease of SCCAI score in all patients (A) and in patients with a SCCAI ≥5 at baseline (B) during the initial 56 days of treatment with tofacitinib. The dashed line depicts a SCCAI = 5.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.